TP53 and cancer: We expect to identify prognostic genes related to the p53 pathway via a combination of pooled shRNA library screening to select genes that are sensitive or resistant to p53-activating drugs and bioinformatics analysis to assess the effects of genes on the survival of patients with cancer depending on p53 mutational status (Figure 1C).